CLINICAL OUTCOMES STUDIES (COS)
Efficacy/Effectiveness (EE) Co-morbidities (CMB) Adverse Events (SE) Diagnosis (D)	Survival (S) Risk Factors (RF) Prevalence (PV)
COST STUDIES (CS)
Budget Impact (BI) Cost-Benefit Analysis (CB) Cost-Effectiveness Analysis (CE) Cost-Efficiency Analysis (CEE) Cost-consequence (CN) Cost-Minimization Analysis (CM)	Cost-Utility Analysis (CU) Cost of Illness (CoI) Cost of Treatment (CoT) Cost Comparison (CC) Productivity/Indirect Costs (PI) Resource Use (RU)
PATIENT REPORTED OUTCOMES STUDIES (PRO)
Adherence/Compliance (AD) Quality-of-Life (QoL) Health States/Utilities (hrQol) Patient Reported Outcomes (PRO) Work Performance/Productivity (WP)	Willingness-to-Pay (WTP) Patient Preference (PP) Patient Satisfaction (PS) Treatment Satisfaction (TS)
HEALTH CARE USE & POLICY STUDIES (HP)
Consumer Role in Health Care (CRH) Diagnosis Related Group (DRG) Disease Management (DISM) Drug or Devices & Health Policy (DHP) Drug Use (DU) Equity and Access (EA) Formulary Development (FD) Health Care Reimbursement (HR) Health Care Expenditure (HE) Health Care Management including pharmaceutical care (HM)	Health Care Information (HI) Medical Devices/Diagnostics (MD) Patient / Provider / Payer / Researcher Education (PE) Patient Registries (PR) Pharmacogenomics (PG) Post Marketing Studies (PMS) Prescribing Behavior (PB) Quality of Care including Quality Improvement (QC) Regulation of Health Care Sector (RHS) Treatment Patterns / Guidelines (TPG)
METHODS AND CONCEPTS (MC)
Clinical Outcomes Studies (CO) Costs Studies including CE/CB/CU, resources use, and productivity (CS) Database Studies & Management (DM)	Study & Methods Design-General (SD) Modeling Studies (MS) Patient Registry (PR) Quality of Life / PRO / Utility / Preference Studies (QOL)

DISEASE/DISORDER FOR RESEARCH SUBMISSIONS:

When submitting your abstract, you must select the DISEASE/ DISORDER that best describes your research. If no disease or multiple diseases apply to your abstract, select Multiple Diseases/No Specific Disease. If the disease area is not listed, select Other.
 

ABSTRACT REVIEW PROCESS AND NOTIFICATION OF AUTHORS:

• All research abstracts will be peer reviewed by at least 3-blinded reviewers.

• Research abstracts will be evaluated based on the criteria listed below.

• All presenters will be notified by email by 2 August 2006.

CRITERIA FOR EVALUATION OF RESEARCH ABSTRACTS:

Note: For studies involving data collection or analysis, the abstract will be REJECTED if RESULTS are NOT included.

Quality Of The Study Criteria For Research Study Abstracts:
1. Research design is appropriate and transparent.
2. Data sources are appropriate and transparent.
3. Data analyses are appropriate and transparent.
4. Results ARE INCLUDED and are transparent and comprehensible.
5. Conclusions are consistent with the results.

Methods And Concepts Abstract Criteria:
1. Approach to method and/or concept is apparent.
2. Approach represents advancement or is innovative.
3. Practical implications/recommendations provided.
4. Papers do NOT need to be organized: Objectives: Methods: Results: Conclusions:

Quality of the Abstract Presentation Criteria:
1. Objectives/research questions are clearly stated and objectives are addressed.
2. Factual information is kept separate from interpretations or implications / unbiased presentation.
3. Implications/results, as presented, are easy to understand.

PRESENTATION OF RESEARCH ABSTRACTS:

PODIUM PRESENTATIONS

• All oral presentations will be programmed into 15-minute time slots. You will have 12 minutes for presentation and 3 minutes for questions and discussion. It is important that you not exceed 15 minutes. Financial support for the research must be presented at the beginning of the presentation.

• Audio/visual equipment: An LCD projector and laptop computer will be provided. Slide projection or overhead transparency projection are not allowed.

• YOU ARE REQUIRED TO BRING AT LEAST 150 HANDOUTS OF YOUR PRESENTATION MATERIAL.

• Presenter MUST email electronic slides NOT LESS THAN 10 DAYS in advance of the Meeting/Meeting to the ISPOR office at podium@ispor.org

POSTER PRESENTATIONS

• At least one author must be present during the Author Discussion Hour given below.
  
  Poster Presentation Timetable:
  Session I Poster Presentations
  Poster Set-up: Sunday, 29 October, 11:30 - 12:00
  Poster Display Hours: Sunday, 29 October, 12:00 – Monday, 30 October, 14:00
  Author Discussion Hour: Sunday, 29 October, 18:00 – 19:00
  Dismantle: Monday, 30 October, 14:00 – 14:30
  
  Session II Poster Presentations
  Poster Set-up: Monday, 30 October, 16:30 – 17:00
  Poster Display Hours: Monday, 30 October, 17:00 – Tuesday, 31 October, 17:00
  Author Discussion Hour: Monday, 30 October, 18:00 – 19:00
  Dismantle: Monday, 30 October, 19:00 – 19:30
   

• The abstract title and authors must be placed at the top of the board, and the lettering must be at least 1 inch high. A copy of the abstract, typed in large print, must be placed in the upper left hand corner of the board. Subtitles should correspond to those used in your abstract submission. Illustrations, charts, tables, lettering, and drawings must be readable from distances of at least three feet. Financial support must be displayed at the lower right hand corner of the board.

• Mounting materials will be available on-site.

• YOU ARE REQUIRED TO BRING AT LEAST 150 HANDOUTS OF YOUR PRESENTATION MATERIAL.

WORKSHOP PROPOSAL INFORMATION

GENERAL INFORMATION

• Workshops are designed to share novel and innovative experiences in either the conduct of pharmacoeconomics and outcomes research studies or the interpretation and use of pharmacoeconomics outcomes information in health care policy development.

• Workshop submissions must be organized as follows: Workshop Purpose: Workshop Description.

• Accepted Workshop Submissions are published AS SUBMITTED in the Congress Final Program.
  
  See workshop sample

TOPICS FOR WORKSHOP SUBMISSIONS:

Workshop submissions are accepted on the following TOPICS:

• Clinical Study Methodology

• Cost Study Methodology

• Patient-reported Outcomes Study Methodology

• Preference-based Studies Methodology Including Utility Studies

• Formulary Development Research

• Health Care Policy Development Using Outcomes Research

• Risk Assessment/Risk Management

• Compliance/Persistence

• Patient Registry Development

WORKSHOP REVIEW PROCESS AND NOTIFICATION OF AUTHORS:

• All workshops are peer reviewed by at least 3 reviewers (not blinded).

• Workshop submissions will be evaluated based on relevance and completeness of information presented based on the Workshop Criteria given below.

• Authors will be notified no later than Tuesday, July 25th, 2006 regarding workshop acceptance and placement in the Annual Congress program.

CRITERIA FOR EVALUATION OF WORKSHOPS:
Workshop acceptance is based on the quality of the submission and the topic for discussion

• The workshop objective(s) are clearly stated.

• The objective(s) can be achieved in the 60 minutes allotted for this workshop.

• The information / issue(s) presented are novel or innovative.

• The information / issue(s) presented is valuable to the pharmacoeconomic &
  outcomes researcher or the health care decision-maker.

• There is an audience interactive element in the workshop.

• The workshop does NOT appear to be advertising the presenter’s company’s services or products.

PRESENTATION OF WORKSHOP ABSTRACTS:

• All workshops will be programmed into 60-minute time periods.

• A single presenter or multiple presenters may present workshops.

• A minimum of 15 minutes of structured audience participation is required.

• Visual equipment: an LCD projector and screen will be provided in each room. However, YOU MUST BRING YOUR OWN LAPTOP COMPUTER.

ISSUE PANEL SUBMISSION INFORMATION

GENERAL INFORMATION

Issues Panels are designed to stimulate real debate on new or controversial issues in health economic/pharmacoeconomic and outcomes research or use of outcomes research in health care decision-making.

• An Issue Panel is composed of a moderator and 1 to 2 panelists.

• To assure lively debate, panelists and/or moderator should be from different institutions and/or work environments representing different perspectives to the debate.

• Panelists should present distinct views about the topic

• Issue Panel submissions abstracts must be organized as follows:
  • Title: Full title of your Issue Panel (showing the debate issue in the title is recommended)
  • Moderator and/or Contact Person: Name, degrees, position, and full contact information for the Moderator of the Issue Panel
  • Panelists: Names, degrees, positions, and full contact information for the Issue Panelists. A maximum of three panelists is suggested. Each panelist should represent a different point of view.
  • Issue: A clear definition of the issue should be described indicating the perspectives to be presented (with panelists named for each perspective)
  • Overview: Background information on the issue(s) should be included.

• Accepted abstracts are published AS SUBMITTED in the Congress Final Program.
  
  See An Issue Panel Example

TOPICS FOR ISSUE PANEL SUBMISSION
Issue Panel submissions are accepted on (but not excluded to) the following topics:

• Pharmacoeconomic / Health Economic Study Methodology Issues

• Quality of Life / Patient-Reported Outcomes Study Methodology Issues

• Utility (Preference-based) Study Methodology Issues

• Clinical Outcomes (treatment guidelines)

• Health Policy

• Health Care Reimbursement / Coverage Issues

• Risk Assessment Study Issues

• Use Of Health Economic/Pharmacoeconomic Information By Decision-Makers

ISSUE PANEL SUBMISSION REVIEW PROCESS AND NOTIFICATION OF AUTHORS:

• Issue Panel submissions are reviewed by the Issue Panel Chair(s)

• Proposals will be evaluated based on topic, relevance to meeting theme and completeness of information presented based on the criteria given above

• Authors will be notified no later than Tuesday, July 25th, 2006 regarding issue panel acceptance and placement in the Annual Congress program

CRITERIA FOR EVALUATION OF THE ISSUE PANEL

• Is the issue clearly defined?

• Is more than 1 perspective identified?

• Is the background information (included in the overview) clear and concise?

• Is there time allotted for audience discussion and debate?

PRESENTATION OF ISSUE PANELS

• All Issues Panels will be 60 minutes.

• 20-30 minutes of audience participation is required

• An LCD projector screen and microphones will be provided. However, YOU MUST BRING YOUR OWN LAPTOP COMPUTER.